Matrix metalloproteinases (MMPs) have been implicated in the cartilage degradation. PG-530742 inhibits some MMPs, potentially limiting cartilage degradation and disease progression. This study will test the efficacy and safety of PG-530742 in the treatment of mild to moderate knee osteoarthritis.
Matrix metalloproteinases have been implicated in the cartilage degradation that occurs in osteoarthritis. PG-530742 inhibits some of these matrix metalloproteinases, thus potentially limiting cartilage degradation and disease progression. This study will test the efficacy and safety of PG-530742 in the treatment of mild to moderate knee osteoarthritis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
395
One 25 mg PG-530742 tablet, twice daily for for one year
One placebo tablet, twice daily for for one year
One 50 mg PG-530742 tablet, twice daily for for one year
Change in Minimum Joint Space Width in the Medial Compartment of the Tibiofemoral Joint of the Signal Knee After 1 Year of Treatment
The structural primary efficacy endpoint is the 1-year change from baseline in minimum joint space width (JSW) in the medial compartment of the tibiofemoral joint of the signal knee, as measured by microfocal knee radiographs obtained in the semi-flexed position.
Time frame: baseline and 12 months
Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score at 1 Year
The symptomatic primary efficacy endpoint is the change in total WOMAC scores after 1 year of treatment. The WOMAC consists of 24 items divided into 3 subscales: Pain (5 items), Stiffness (2 items), Physical Function (17 items). The WOMAC uses descriptors for all items: none, mild moderate, severe, and extreme (corresponding to an ordinal scale of 0-4.) Scores are summed for items in each subscale, with possible ranges as follows: pain=0-20, stiffness=0-8, physical function=0-68. The total WOMAC score is created by summing the items for all three subscales (min=0, max=96)
Time frame: baseline and 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
100 mg PG-530742 tablet, twice a day for one year
200 mg PG-530742 tablet, twice a day for one year
Rehabilitation Hospital, Gizella telep
Visegrád, Gizella Telep, Hungary
Petz A. Country Hospital, Department of Rheumatology, Hid utca 2.
Győr, Hid Utica 2, Hungary
National Institute of Rheumatology and Physiotherapy, Dept. of Rheumatology and Immunology, Frankel Leo u. 38-40
Budapest, Hungary
National Institute of Rheumatology and Physiotherapy, Dept. of Rheumatology I and Metabolic Osteology, Frankel Leo u. 38-40
Budapest, Hungary
National Institute of Rheumatology and Physiotherapy, Dept. of Rheumatology IV., Frankel Leo u. 38-40
Budapest, Hungary
Orthopedic Clinic, Karolina ut 17
Budapest, Hungary
Szent Ferenc Hospital, Department of Rheumatology, Csabai Kapu 42.
Miskolc, Hungary
95 Stanwell Road
Ashford, Middlesex, United Kingdom
Royal National Orthapaedic Hsopital, Brackley Hill
Stanmore, Middlesex, United Kingdom
St Thomas Hospital, Lambeth Place Road
London, Se17eh, United Kingdom
...and 13 more locations